gamma-aminobutyric acid A receptor, alpha 2 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
FLEROXACIN |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
MYCOPHENOLATE MOFETIL |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
FLUORESCEIN |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
DIFLUNISAL |
Sigma1 |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 5 (DBSS) |
CYTARABINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1b |
CYTARABINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 1a |
CYTARABINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 4 |
CYTARABINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) |
CYTARABINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
CYTARABINE |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
CITRININ |
Atrial Natriuretic Factor (ANF) |
-16% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
CITRININ |
Atrial Natriuretic Factor (ANF) |
-16% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
CITRININ |
Atrial Natriuretic Factor (ANF) |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 4 |
CITRININ |
Muscarinic M4 |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
DICYCLOMINE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
DICYCLOMINE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
DICYCLOMINE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
DICYCLOMINE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
ATROPINE |
Adenosine A1 |
-16% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
FUROSEMIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
FUROSEMIDE |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
SULINDAC |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CLOTRIMAZOLE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
CLOTRIMAZOLE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
CLOTRIMAZOLE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BETA-ESTRADIOL 3-BENZOATE |
Cyclooxygenase COX-1 |
-16% |
NoneNone |
NoneNone |
View
|
lymphocyte protein tyrosine kinase (mapped) |
AMANTADINE |
Protein Tyrosine Kinase, Lck |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
AMIFOSTINE |
Phosphodiesterase PDE5 |
-16% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 5A, cGMP-specific |
AMIFOSTINE |
Phosphodiesterase PDE5 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
AMIFOSTINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) |
AMIFOSTINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-16% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) |
AMIFOSTINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-16% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
AMIFOSTINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-16% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) |
AMIFOSTINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-16% |
NoneNone |
NoneNone |
View
|
protein phosphatase 3, catalytic subunit, beta isoform |
AMIFOSTINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-16% |
NoneNone |
NoneNone |
View
|
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) |
AMIFOSTINE |
Protein Serine/Threonine Phosphatase, Calcineurin PP2B |
-16% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Tumor Necrosis Factor (TNF), Non-Selective |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
LACTIC ACID |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
LACTIC ACID |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
BETAMETHASONE |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
BETAMETHASONE |
Serotonin 5-HT4 |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
ALPRAZOLAM |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
ALPRAZOLAM |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
ALPRAZOLAM |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
ALPRAZOLAM |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
histamine receptor H 1 |
4-OCTYLPHENOL |
Histamine H1, Central |
-16% |
NoneNone |
NoneNone |
View
|
melanocortin 5 receptor |
BIS(2-ETHYLHEXYL)PHTHALATE |
Melanocortin MC5 |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 4 |
TROMETHAMINE |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 3 |
TROMETHAMINE |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 2 |
TROMETHAMINE |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 1 |
TROMETHAMINE |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, kainate 5 |
TROMETHAMINE |
Glutamate, Kainate |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
PROGESTERONE |
Serotonin 5-HT2B |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
BIS(2-ETHYLHEXYL)PHTHALATE |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
BIS(2-ETHYLHEXYL)PHTHALATE |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
MESTRANOL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
MESTRANOL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
MESTRANOL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
MESTRANOL |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
BIS(2-ETHYLHEXYL)PHTHALATE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
BIS(2-ETHYLHEXYL)PHTHALATE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
CAPTOPRIL |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 1a |
3-ACETAMIDOPHENOL |
Adrenergic alpha1A |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
ALTRETAMINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
ALTRETAMINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
ALTRETAMINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
ALTRETAMINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
ALTRETAMINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
ALTRETAMINE |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
BETA-ESTRADIOL 3-BENZOATE |
Cyclooxygenase COX-1 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
PREDNISONE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
PREDNISONE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
CIPROFIBRATE |
Chemokine CXCR2 (IL-8B) |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
MICONAZOLE |
Muscarinic M5 |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
VANCOMYCIN |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
VANCOMYCIN |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 1A |
PIMARICIN |
Serotonin 5-HT1A |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
FLUOROURACIL |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
FLUOROURACIL |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
INDOMETHACIN |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
INDOMETHACIN |
Thromboxane Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
METYRAPONE |
Adrenergic beta1 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
METYRAPONE |
Adrenergic beta1 |
-16% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
BENZO[A]PYRENE |
Purinergic P2X |
-16% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
BENZO[A]PYRENE |
Purinergic P2X |
-16% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
BENZO[A]PYRENE |
Purinergic P2X |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
FENOFIBRATE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 10 |
METHOTREXATE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, epsilon polypeptide |
METHOTREXATE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 4 |
METHOTREXATE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 5 |
METHOTREXATE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
METHOTREXATE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
ERGOCORNINE |
Serotonin Transporter |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, nicotinic, alpha polypeptide 9 |
METHOTREXATE |
Nicotinic Acetylcholine, Central |
-16% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
Y-27632 |
Vasopressin V1A |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
BUDESONIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
BUDESONIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor |
BUDESONIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene B4 receptor 2 |
BUDESONIDE |
Leukotriene B4 |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, beta |
ACETAZOLAMIDE |
Chemokine CXCR2 (IL-8B) |
-16% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
ALPHA-TOCOPHEROL |
Cannabinoid CB1 |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
ACETAZOLAMIDE |
Chemokine CCR4 |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 2 |
(+)-THALIDOMIDE |
Muscarinic M2 |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
CYCLOPHOSPHAMIDE |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
CYCLOPHOSPHAMIDE |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase (YT blood group) |
CYCLOHEXIMIDE |
Acetylcholinesterase |
-16% |
NoneNone |
NoneNone |
View
|
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase |
CYCLOHEXIMIDE |
Acetylcholinesterase |
-16% |
NoneNone |
NoneNone |
View
|
acetylcholinesterase |
CYCLOHEXIMIDE |
Acetylcholinesterase |
-16% |
NoneNone |
NoneNone |
View
|